Stryker (SYK) News
NYSE: SYKHealth CareMedical/Dental InstrumentsUSD
310.00-3.08 (-0.98%)
At close: Nov 20, 4:01 PM ET · Delayed 15 min
SYK news summary
We found 50 recent headlines mentioning Stryker (SYK): 6 in the past week and 30 in the past 30 days, most often from Nasdaq, Seeking Alpha, GlobeNewswire. For price context, SYK is down 0.98% at $310.00. The most recent story, "Stryker: A Great Franchise Still Has Something To Prove", was published by Seeking Alpha on Nov 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Stryker headlines
- Stryker: A Great Franchise Still Has Something To ProveSeeking Alpha
- Stryker Sticks to Growth Goals Despite Cyberattack and Slower Orthopedic Market3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the MostStryker (NYSE:SYK) expects to maintain its long-term growth and margin goals despite a cyberattack, supply disruptions…Nasdaq
- General Dynamics wins $332.5M Army contract for Stryker supportSeeking AlphaGD, SYK
- ISRG EPS Climbs 25% to $3: Is Innovation Driving Profitable Growth?Intuitive Surgical's adjusted EPS surged 25% as robotic platform adoption and AI innovation fueled growth, despite rising R&D costs and a litigation settlement.NasdaqISRG, MDT, SYK
- Stryker Corporation (SYK) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha
- GEHC or SYK: Which Is the Better Value Stock Right Now?GEHC vs. SYK: Which Stock Is the Better Value Option?NasdaqGEHC, SYK
- Why did Stryker surge 19% after cutting full-year guidance?Investing.com
- Stryker Corporation Increases Board Size to 12 and Elects James E. DavisOn November 3, 2026, the Board of Directors of Stryker Corporation (the “Company”) increased the number of authorized directors from 11 to 12 and elected James E. Davis to fill the…Nasdaq
- Are Options Traders Betting on a Big Move in Stryker Stock?Investors need to pay close attention to SYK stock based on the movements in the options market lately.Nasdaq
- Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy?Key PointsMedtronic recently completed a key spinoff of its diabetes segment.NasdaqMDT, JNJ, SYK, ABT
- SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook CutStryker shares plunge 11.8% after Q3 earnings and sales miss estimates, prompting a 2026 outlook cut amid weak joint procedures and execution challenges.NasdaqSYK, BDX, GMED, GKOS
- Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSSSAN FRANCISCO, Oct. 30, 2026 /PRNewswire/ -- On September 8, 2026, investors in Stryker Corporation (NYSE: SYK) saw the price of their shares fall $26.70 (-8.8%) after the company's CFO revealed that…PR Newswire
- Stryker (SYK) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?J&J's MedTech growth slows in Q3 amid international market challenges and Abiomed weakness.NasdaqJNJ, BSX, MDT, SYK
- SYK Q3 Earnings Call Highlights Softer Demand and Revised OutlookStryker cuts its 2026 outlook amid weaker joint replacement demand and supply disruptions, despite MedSurg strength, margin gains and robotics investments.Nasdaq
- What Stryker (SYK) Said on Its Q3 Earnings Call3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the MostStryker (NYSE:SYK) reported third-quarter organic sales growth of 7.7% and adjusted earnings per share of $3.52, while…Nasdaq
- Stryker Corporation Reports Third Quarter 2026 Operating ResultsStryker Corporation reported its operating results for the third quarter of 2026, with reported net sales increasing 7.7% to $6.5 billion and organic net sales increasing 7.7%. Reported net earnings…NasdaqSYK, BIO.B
- Stryker anticipates 6.5% to 7% organic net sales growth in 2026 as it plans to scale Versius in the U.S.Seeking Alpha
- Stryker Corporation (SYK) Q3 2026 Earnings Call TranscriptSeeking Alpha
- Stryker falls following profit guidance cut, Q3 missesSeeking Alpha
- Stryker (SYK) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesAlthough the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…Nasdaq
- Stryker (SYK) Q3 Earnings and Revenues Lag EstimatesStryker (SYK) delivered earnings and revenue surprises of -1.12% and -0.88%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqSYK, PRGO
- Stryker Corp. Profit Declines In Q3(RTTNews) - Stryker Corp. (SYK) announced earnings for third quarter that Drops, from last yearNasdaq
- Stryker reports third quarter 2026 operating resultsPortage, Michigan, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2026:GlobeNewswire
- Notable Thursday Option Activity: PWR, NCLH, SYKLooking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Quanta Services, Inc. (Symbol: PWR), where a total volume of 5,295 contracts has been…NasdaqPWR, NCLH, SYK
- SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?SYK's Q3 earnings may reflect strong hospital equipment demand and cybersecurity recovery, but supply constraints, vascular disruptions and margin pressures remain.NasdaqSYK, EW, GMED, GKOS
- It's Too Soon To Upgrade Stryker CorporationSeeking Alpha
- Stryker Completes ZuriMED Deal, Adds FiberLocker System To Sports Medicine Portfolio(RTTNews) - Stryker Corp. (SYK), a medical technology company, on Monday announced the completion of its acquisition of ZuriMED, a privately held company that developed the FiberLocker System, to…Nasdaq
- Countdown to Stryker (SYK) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSGet a deeper insight into the potential performance of Stryker (SYK) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for…Nasdaq
- Stryker completes acquisition of ZuriMED to enhance its shoulder offeringPortage, Michigan, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced it has completed the acquisition of ZuriMED, a privately held company and…GlobeNewswire
- Stryker stock may move 6.3% on Oct. 29 earnings releaseInvesting.com
- Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseStryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.NasdaqSYK, BSX
- PAHC or SYK: Which Is the Better Value Stock Right Now?PAHC vs. SYK: Which Stock Is the Better Value Option?NasdaqPAHC, SYK
- 2 Dividend Stocks to Buy and Hold ForeverKey PointsProcter & Gamble has increased its dividend for 70 consecutive years.NasdaqPG, SYK
- Stryker's Sonopet 3 Secures FDA Clearance to Improve Surgical AccuracySYK's Sonopet 3 secures FDA clearance, promising enhanced surgical precision and efficiency, with a full commercial launch expected later this fall.NasdaqSYK, MMSI, OPK, GMED
- Why ISRG Is Lowering Instrument Costs Despite Strong ProfitabilityIntuitive Surgical plans to extend instrument life in 2027, trading near-term revenue per procedure for lower surgical costs and broader robotic surgery adoption.NasdaqISRG, MDT, SYK
- The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic ServicesHealthcare and waste management offer long-term demand opportunities beyond AI in 2027, with Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services in focus.NasdaqABT, JNJ, SYK, WM
- Stryker Enters Soft-Tissue Robotics With $400 Million CMR DealSYK's $400 million investment in CMR Surgical marks its entry into soft-tissue robotics, expanding its surgical portfolio with Versius technology.NasdaqSYK, JNJ, MDT, ISRG
- ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?Intuitive Surgical's Q3 earnings hinge on robotic surgery growth, system demand and margins amid slowing US procedures, China headwinds and premium valuation.NasdaqISRG, SYK, GEHC
- ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell?Intuitive Surgical shares have surged nearly 12% in a month ahead of Q3 earnings. Strong da Vinci 5 adoption and Ion growth fuel momentum, but valuation and risks linger.NasdaqISRG, MDT, SYK
- Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance?J&J's shares fell 5.8% despite an earnings beat and raised guidance, as MedTech weakness, drug sales shortfalls and acquisition costs weighed on results.NasdaqJNJ, BSX, MDT, SYK
- Stryker: Q2 Recovery And Portfolio Expansion Strengthen The Operating StorySeeking Alpha
- ASML: A Rule Breaker Test of Lasting LeadershipIn the early 2000s, ASML (NASDAQ:ASML) committed to a technology that much of the microchip industry doubted would ever work. Extreme ultraviolet lithography, or EUV, prints chip circuits with light…NasdaqASML, NVDA, TSM, MSFT
- Stryker, CMR Surgical Form Strategic Alliance To Advance Robotic-Assisted Surgery(RTTNews) - Stryker Corp. (SYK), a medical technology company, announced a strategic equity investment of approximately $400 million (300 million Euros), with an exclusive option to acquire the…Nasdaq
- Stryker to invest $400M in CMR Surgical, gains buyout optionSeeking Alpha
- Stryker To Invest In CMR Surgical; To Serve As U.S. Sales Agent For Versius Portfolio(RTTNews) - Stryker (SYK) and CMR Surgical, a global robotics company, announced a strategic equity investment of approximately $400 million by Stryker with an exclusive option for Stryker to acquire…Nasdaq
- Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgeryPortage, Mich., USA and Cambridge, England, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Strategic alliance combines CMR Surgical’s established platform and robotics expertise with Stryker’s scale, customer…GlobeNewswire
- Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Misses Revenue EstimatesTilray Brands (TLRY) delivered earnings and revenue surprises of -68.42% and -1.98%, respectively, for the quarter ended August 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqTLRY, SYK
- Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTechSeeking AlphaGEHC, SYK, BCS
- Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTechSeeking AlphaSYK, BCS